FOLFOXIRI Protocol clinical trials

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

This study looks into better ways to treat a specific type of advanced cancer called Grade 3 Neuroendocrine Carcinoma. Researchers are testing a new chemotherapy combination to see if it works better than the usual treatment, hoping for improved survival and understanding which treatments suit different patients best.